EXEL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:41):
Our systems believe the stock currently is undervalued by 0.00% compare to its pairs and should correct upwards.

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States...

Stats
Today's Volume	166 137
Average Volume	2.00M
Market Cap	6.46B
EPS	$0.120 ( Q1 \| 2024-04-30 )
Next earnings date	( $0.370 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	34.11 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0110 (0.05%)

AADI -3.53%

ABCL 1.47%

ABCM 0.04%

ABEO -2.37%

ABIO -2.23%

ABOS 0.00%

ABSI 1.70%

ABUS -2.30%

ABVX -2.03%

ACAD -0.64%

ACER -17.95%

ACET -5.41%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.75%

ACLX 0.25%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -3.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.86%

ADPT -0.14%

ADTX -3.47%

ADVM -3.47%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.87%

AGEN -2.82%

AGIO -2.55%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.28%

AKRO -3.15%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.52%

ALEC -1.83%

ALGS -2.06%

ALKS -0.25%

ALLK -8.90%

ALLO -4.79%

ALLR -3.41%

ALNA 3.16%

ALNY 2.36%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.51%

ALVR -0.40%

ALXN 0.00%

ALXO -10.89%

ALZN 2.04%

AMRN 0.56%

AMTI -3.13%

ANAB 0.84%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.42%

ANPC -3.15%

APGE -1.25%

APGN 8.48%

APGNW 30.65%

APLM -5.01%

APLS 0.12%

APLT -3.94%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.61%

ARDS -14.23%

ARDX -0.66%

ARGX -0.74%

ARNA 0.00%

ARPO -0.90%

ARQT -1.41%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.23%

ARWR -1.75%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.48%

ATHA 5.48%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -1.00%

AUPH -0.90%

AURA 1.18%

AUTL -1.87%

AVBP -4.23%

AVEO 0.00%

AVIR -0.29%

AVRO -1.41%

AVTE -5.52%

AVTX -1.25%

AVXL -3.21%

AXLA 0.00%

AXSM -1.88%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.77%

BCAB 2.94%

BCDA -2.05%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 1.26%

BDRX -4.94%

BDTX -1.07%

BEAM 0.58%

BFRA -2.91%

BGNE -3.00%

BIOR -3.80%

BIVI 4.64%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.34%

BMEA -11.13%

BMRN 0.47%

BNOX -2.22%

BNTC -2.39%

BNTX -1.83%

BOLD -8.58%

BOLT 0.72%

BPMC -1.25%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 24.58%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.42%

CADL -2.12%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.24%

CARM 11.34%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.50%

CCCC -5.10%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.68%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.21%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.09%

CERO -3.47%

CEROW -10.18%

CFRX -27.95%

CGEM -2.56%

CGEN -3.87%

CGON -1.56%

CGTX -4.47%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.26%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.29%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 6.99%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.97%

CMND 0.78%

CMPI 0.00%

CMPX -8.25%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -38.03%

CNST 0.00%

CNTA -0.51%

CNTB -2.25%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -3.00%

CORT 1.97%

COYA -1.46%

CPRX -1.22%

CRBP -3.36%

CRBU -4.58%

CRDF -2.20%

CRGX 0.47%

CRIS -0.38%

CRNX -6.15%

CRSP 1.11%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.55%

CTXR 1.36%

CUE 4.50%

CVAC -2.82%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.85%

CYTO -1.82%

DARE 6.33%

DAWN 0.30%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -1.70%

DNTH -7.88%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -3.12%

EDSA 3.19%

EFTR 1.32%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.05%

ELYM 1.26%

ENGN -4.44%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB 1.10%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX -0.40%

EXAI -0.66%

EXEL -0.40%

EYEG -0.69%

EYEN 1.45%

EYPT 0.00%

FATE -7.80%

FBIO 0.59%

FBIOP 0.92%

FBLG -18.30%

FBRX -0.04%

FDMT -4.52%

FENC -1.29%

FGEN -5.56%

FHTX 1.91%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.74%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.09%

FULC -4.19%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -1.54%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.32%

GHRS -2.16%

GLMD -2.33%

GLPG -2.27%

GLSI 2.76%

GLTO -0.57%

GLUE -2.37%

GLYC -9.86%

GMAB -0.50%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 0.00%

GNLX 1.33%

GNPX 0.98%

GNTA 3.94%

GOSS -9.79%

GOVX 5.01%

GOVXW -49.04%

GPCR -6.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.69%

GRTX 2.57%

GTHX 0.45%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.49%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.31%

HOOK -0.02%

HOTH -2.70%

HOWL -1.92%

HRMY 0.66%

HRTX 3.44%

HSTO 0.00%

HUMA 0.30%

HUMAW -0.01%

IBRX -4.47%

ICCC 0.22%

ICPT 0.21%

ICU 15.60%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.58%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.22%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.99%

INAB 0.00%

INBX 0.53%

INCY -0.90%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.49%

INMB 2.60%

INO -2.34%

INSM -1.15%

INTS -2.75%

INVA 0.22%

INZY 0.69%

IOBT -11.42%

IONS 0.10%

IOVA -2.54%

IPA 2.50%

IPHA 5.58%

IPSC -2.15%

IRON -2.94%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 1.68%

JANX -4.24%

JAZZ -0.74%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.69%

KNTE -0.38%

KOD -7.91%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -0.95%

KTRA 14.61%

KTTA 8.16%

KTTAW 0.92%

KURA -1.59%

KYMR -2.38%

KYTX -4.65%

KZIA 2.65%

KZR -0.88%

LABP 0.57%

LBPH -2.79%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.28%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.71%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.09%

LPCN -3.93%

LPTX -1.65%

LQDA -1.22%

LRMR -2.35%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX 0.00%

LXEO -4.21%

LXRX -2.06%

LYEL -33.50%

LYRA 1.16%

MACK 0.10%

MBIO -11.32%

MBRX -2.57%

MCRB 2.56%

MDGL -3.53%

MDNA -13.16%

MDWD 0.07%

MDXG -2.72%

MEIP -0.13%

MESO -1.93%

MGNX -3.03%

MGTA -7.74%

MGTX -3.33%

MGX 0.54%

MIRM -1.73%

MIRO 0.59%

MIST 0.76%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.83%

MLYS -6.90%

MNKD -1.16%

MNMD 0.35%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.34%

MREO -4.14%

MRKR 2.68%

MRNA -5.32%

MRNS -4.06%

MRSN -2.14%

MRTX -0.17%

MRUS 0.28%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -1.24%

MYMD 5.41%

NAMS 2.04%

NAMSW 0.43%

NAUT 1.56%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 2.60%

NGM -1.28%

NGNE -1.93%

NKGN 10.62%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.06%

NLSP 7.12%

NLSPW 26.67%

NMRA -2.96%

NMTR -42.97%

NOVN -24.84%

NRBO 9.15%

NRIX -0.39%

NRSN -6.31%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.58%

NTRBW -31.07%

NUVL -1.82%

NVAX -2.43%

NVCT 2.89%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.35%

OBSV 0.00%

OCEA 0.00%

OCGN 3.83%

OCS -1.00%

OCUL -1.83%

OCUP 1.30%

ODT -4.27%

OKYO 1.51%

OLMA -6.05%

OMER -0.51%

OMGA 4.15%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.56%

ORMP 20.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.36%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.58%

PDSB -2.53%

PEPG 2.62%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.55%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.37%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.37%

PLUR 6.01%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -10.93%

PRAX 0.37%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.01%

PRTA -2.77%

PRTC 0.49%

PRTG -0.68%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -7.32%

PSTX -1.16%

PTCT -0.74%

PTE -0.82%

PTGX -1.89%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.96%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.67%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.10%

RCKT -8.37%

REGN -0.42%

RENB -2.80%

REPL -2.95%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -6.01%

RIGL -3.29%

RLAY -5.04%

RLMD 0.33%

RLYB -0.34%

RNA -0.50%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.12%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.15%

RPTX -2.64%

RUBY 2.70%

RVLP -32.05%

RVMD -1.25%

RVMDW -30.00%

RVNC 1.92%

RVPH -1.60%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.57%

RYTM -6.74%

RYZB 0.02%

RZLT 1.16%

SABS -1.37%

SABSW -11.81%

SAGE 1.38%

SANA -4.05%

SAVA -0.73%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -5.26%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.22%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -5.69%

SLGL 2.97%

SLN -4.76%

SLNO -4.08%

SLRX 6.07%

SLS -2.14%

SMMT -2.87%

SNDX 1.20%

SNGX -3.42%

SNPX -0.79%

SONN -1.08%

SPPI -0.49%

SPRB 1.52%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.30%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -5.27%

STRO -2.82%

STSA 0.00%

STTK -2.68%

SURF -0.93%

SVRA -4.74%

SWTX -0.11%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -6.73%

TARS -0.41%

TBPH 0.30%

TCBP 2.47%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.16%

TENX -1.27%

TERN -7.83%

TFFP -5.21%

TGTX -3.23%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.11%

TNGX -2.92%

TNXP -4.81%

TNYA -7.18%

TPST 3.28%

TRDA -3.93%

TRVI 1.92%

TRVN 2.97%

TSHA -24.70%

TSVT -3.19%

TTNP -9.27%

TVTX 0.76%

TYRA -6.83%

UBX -2.12%

UNCY -3.82%

URGN -1.17%

UTHR -0.55%

VACC 11.36%

VALN -2.89%

VAXX 68.75%

VBIV 0.78%

VBLT -8.77%

VCEL -0.42%

VCNX 10.35%

VCYT -1.03%

VERA -3.85%

VERU -0.57%

VERV -2.87%

VIGL 7.53%

VINC 3.00%

VIR 0.65%

VIRI -1.61%

VIRX 2.40%

VKTX -1.57%

VLON -13.04%

VNDA -2.69%

VOR -1.61%

VRCA 0.14%

VRDN -4.47%

VRNA -1.66%

VRPX 0.38%

VRTX 0.32%

VSTM -2.38%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.75%

VYGR -1.53%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -1.46%

XCUR 3.58%

XENE -3.14%

XERS 1.67%

XFOR 2.09%

XLO 4.54%

XLRN 0.00%

XNCR 0.21%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.87%

ZNTL -0.99%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-04	Wyszomierski Jack L	Sell	8 287	Common Stock
2024-05-31	Papadopoulos Stelios	Buy	18 838	Common Stock
2024-05-31	Poste George	Buy	18 838	Common Stock
2024-05-31	Freire Maria C	Buy	18 838	Common Stock
2024-05-31	Heyman Tomas J.	Buy	18 838	Common Stock

INSIDER POWER
35.49
Last 97 transactions
Buy: 3 648 358 \| Sell: 1 868 617

Correlation (AI algo v.1.1b): Undervalued: 0.00% $22.17 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.05 (neutral)

Short: 0.62 (weak)

Signal:(40.711) Neutral

Exelixis Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations
OTTR	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Exelixis Inc Correlation - Currency/Commodity

0.32
( neutral )

-0.26
( neutral )

0.00
( neutral )

0.04
( neutral )

0.28
( neutral )

0.27
( neutral )

Exelixis Inc Financials

Annual	2023
Revenue:	$1.83B
Gross Profit:	$1.76B (96.04 %)
EPS:	$0.650

FY	2023
Revenue:	$1.83B
Gross Profit:	$1.76B (96.04 %)
EPS:	$0.650

FY	2022
Revenue:	$1.61B
Gross Profit:	$1.55B (96.41 %)
EPS:	$0.570

FY	2021
Revenue:	$1.43B
Gross Profit:	$1.38B (96.32 %)
EPS:	$0.733

Financial Reports:

No articles found.

Exelixis Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Exelixis Inc

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.